elliptinium has been researched along with Glioma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ali-Osman, F; Dougherty, D; Giblin, J; Rosenblum, ML | 1 |
| Ali-Osman, F; Giannini, DD; Levin, VA; Rosenblum, ML | 1 |
2 other study(ies) available for elliptinium and Glioma
| Article | Year |
|---|---|
Application of in vivo and in vitro pharmacokinetics for physiologically relevant drug exposure in a human tumor clonogenic cell assay.
Topics: Antineoplastic Agents; Aziridines; Benzoquinones; Biological Assay; Brain Neoplasms; Carmustine; Cell Line; Cisplatin; Clone Cells; Dose-Response Relationship, Drug; Ellipticines; Glioma; Half-Life; Humans; Mathematics; Streptozocin; Teniposide | 1987 |
Potential antiglioma activity of 9-hydroxy-2-N-methylellipticine as determined by pharmacological and human tumor clonogenic cell studies.
Topics: Alkaloids; Antineoplastic Agents; Brain; Brain Neoplasms; Capillary Permeability; Cell Line; Ellipticines; Glioma; Humans; Kinetics; Tumor Stem Cell Assay | 1985 |